Walgreens Boots Alliance Inc.
American multinational pharmacy-led health and retail company operating retail pharmacies, health and wellness services, and pharmaceutical wholesale distribution.
Company Type
public
Founded
2014
Headquarters
Deerfield, Illinois, USA
Stock
NASDAQ: WBA
Revenue
approximately $147.7 billion (FY2024)
Employees
Approximately 330,000
Primary Market
Global
science based targets
About Walgreens Boots Alliance Inc.
Walgreens Boots Alliance operates through three main segments: Retail Pharmacy USA, Retail Pharmacy International, and Pharmaceutical Wholesale. The Retail Pharmacy USA segment includes Walgreens drugstores, Duane Reade stores, and healthcare services across the United States.
The Retail Pharmacy International segment includes Boots stores and other pharmacy operations in the UK, Thailand, Norway, Ireland, Netherlands, and other international markets. The segment also includes the No7 Beauty brand and other health and beauty product lines.
The Pharmaceutical Wholesale segment, operated through Alliance Healthcare, provides wholesale distribution services to pharmacies, doctors, and healthcare providers across Europe. This segment ensures efficient distribution of pharmaceuticals and healthcare products.
Walgreens Boots Alliance employs approximately 325,000 people worldwide and generates annual revenues exceeding $130 billion. The company serves millions of customers daily through its retail pharmacies and healthcare services, making it a critical component of the healthcare delivery system.
History of Walgreens Boots Alliance Inc.
Walgreens Boots Alliance was formed on December 31, 2014, through the merger of Walgreens and Alliance Boots, creating the first global pharmacy-led health and wellness retailer. The merger combined Walgreens, the largest drugstore chain in the United States, with Alliance Boots, a leading international pharmacy-led health and beauty retailer.
Walgreens traces its origins to 1901 when Charles R. Walgreen purchased a drug store in Chicago. The company grew throughout the 20th century, becoming one of the largest pharmacy chains in the United States through organic growth and strategic acquisitions, including the acquisition of Duane Reade in 2010.
Alliance Boots was formed in 2006 through the merger of Alliance UniChem and Boots Group. Boots was founded in 1849 by John Boot in Nottingham, England, and grew into one of the UK's leading pharmacy chains. The company expanded internationally through various acquisitions and partnerships.
The 2014 merger created a company with significant global presence, combining Walgreens' strength in the U.S. market with Alliance Boots' international footprint. The company has continued to expand through acquisitions, including the purchase of Rite Aid stores and strategic partnerships in healthcare delivery.
Throughout the 2010s and 2020s, Walgreens Boots Alliance has focused on transforming from a retail pharmacy company to an integrated healthcare provider, expanding into primary care, specialty pharmacy, and digital health services.
Walgreens Boots Alliance Inc. Sustainability & Ethics
Walgreens Boots Alliance has implemented comprehensive sustainability initiatives focused on environmental responsibility, ethical healthcare practices, and community engagement. The company has committed to ambitious climate goals while maintaining its position as a global leader in pharmacy-led health and wellness retail.
The company has established environmental sustainability programs focusing on energy efficiency in stores and distribution centers, waste reduction initiatives, and sustainable product sourcing. Walgreens Boots Alliance has set goals to reduce carbon emissions and increase renewable energy usage across its global operations.
Walgreens Boots Alliance addresses ethical considerations through responsible pharmacy practices, medication safety programs, and healthcare accessibility initiatives. The company maintains comprehensive compliance programs for pharmaceutical distribution and retail pharmacy operations, ensuring adherence to regulatory standards and ethical business practices.
The company has strong community engagement programs, including the Walgreens Boots Alliance Foundation which supports health education, community wellness initiatives, and disaster relief efforts. Walgreens Boots Alliance employees participate in community health programs and volunteer activities, supporting public health initiatives in communities where the company operates.
Awards & Recognition
Walgreens Boots Alliance has received recognition for healthcare innovation, workplace practices, and corporate responsibility:
- **Fortune 500 Most Admired Companies (2024 and 2025):** Recognition as one of the world's most admired companies in healthcare
- **Great Place to Work Certification (2024 and 2025):** Recognition for workplace culture and employee satisfaction across multiple regions
- **Healthcare Innovation Awards (2023):** Recognition for digital health services and pharmacy innovation
- **Environmental Leadership Awards (2024):** Recognition for sustainability initiatives and environmental programs
- **Community Service Awards (Multiple years):** Recognition for community health initiatives and employee volunteer programs
- **Retail Excellence Awards (2023):** Recognition for pharmacy retail innovation and customer service
- **Supply Chain Excellence Awards (2023):** Recognition for pharmaceutical distribution and supply chain management
- **Safety Awards (2024):** Recognition for workplace safety and employee well-being programs
Controversy, Regulation & Public Scrutiny
Walgreens Boots Alliance has faced several controversies and regulatory challenges throughout 2025, primarily related to drug pricing, pharmacy practices, and regulatory compliance. The company has maintained comprehensive compliance programs while addressing various regulatory and public scrutiny issues.
Walgreens Boots Alliance has experienced product recalls affecting various pharmaceutical and over-the-counter products, working closely with regulatory agencies like the FDA to ensure consumer safety. The company maintains rigorous quality control programs and implements voluntary recall procedures when issues arise.
The company has faced extensive scrutiny regarding drug pricing practices and pharmacy benefit management relationships. Walgreens Boots Alliance has been involved in discussions and regulatory proceedings regarding prescription drug pricing transparency and reimbursement rates.
Walgreens Boots Alliance has been involved in controversies related to opioid dispensing practices and pharmacy responsibility in addressing the opioid crisis. The company has implemented enhanced monitoring programs and compliance measures to address these concerns.
The company has faced criticism regarding its retail pharmacy practices and competition with independent pharmacies, particularly concerning market consolidation and competitive practices in certain geographic markets.
Walgreens Boots Alliance has also faced scrutiny regarding its healthcare service delivery and digital health initiatives, particularly concerning data privacy and healthcare accessibility in underserved communities.
Brands Owned by Walgreens Boots Alliance Inc.
Walgreens Boots Alliance Inc. owns 0 brands in our database.
Stock Information
Walgreens Boots Alliance Inc. Ownership: Pros & Cons
Advantages
- +Market leadership position in pharmacy retail in the U.S. and UK
- +Diversified revenue streams across retail, wholesale, and healthcare services
- +Strong brand recognition and customer loyalty
- +Significant scale and purchasing power in pharmaceutical distribution
- +Growing presence in healthcare delivery and digital health services
Considerations
- -Intense competition from other pharmacy chains and online retailers
- -Regulatory scrutiny over drug pricing and pharmacy practices
- -Pressure on healthcare costs and reimbursement rates
- -Balance between retail operations and healthcare service delivery
- -Competition from Amazon and other technology companies entering healthcare
Frequently Asked Questions About Walgreens Boots Alliance Inc.
Is Walgreens Boots Alliance a subsidiary of another company?
Walgreens Boots Alliance is an independent, publicly traded corporation with no parent company. The company operates independently with its own management structure and board of directors, though it was formed through the merger of Walgreens and Alliance Boots in 2014.
Is Walgreens Boots Alliance publicly traded?
Yes, Walgreens Boots Alliance is publicly traded on the NASDAQ stock exchange under the ticker symbol WBA. The company has been publicly traded since the merger in 2014, allowing investors to purchase shares and own a portion of the company.
When was Walgreens Boots Alliance founded?
Walgreens Boots Alliance was formed on December 31, 2014, through the merger of Walgreens and Alliance Boots. However, the company's component businesses have much longer histories, with Walgreens founded in 1901 and Boots founded in 1849.
Who founded Walgreens Boots Alliance?
The modern Walgreens Boots Alliance was created through the merger of Walgreens and Alliance Boots. The merger was led by Walgreens CEO Greg Wasson and Alliance Boots Executive Chairman Stefano Pessina, combining two major pharmacy-led retail companies.
What is Walgreens Boots Alliance's market position?
Walgreens Boots Alliance is the largest pharmacy-led health and wellness retailer globally, with leading positions in the U.S. and UK pharmacy markets. The company maintains strong positions in retail pharmacy, pharmaceutical wholesale, and is expanding into healthcare services and digital health.
Sources & Further Reading
Jobs at Walgreens Boots Alliance Inc.
Latest News About Walgreens Boots Alliance Inc.
Related Articles About Walgreens Boots Alliance Inc.
View more articles
Brand Ownership
15 Pharmacy Brands and Their Corporate Parents
CVS, Walgreens, Rite Aid, and their store-brand equivalents are just the start. Here are 15 pharmacy and drugstore brands, who owns them, and how the retail pharmacy industry consolidated into just a few corporate hands.
Who Brands StaffFeb 26, 2026
pharmacy-brandsbrand-ownershipcvs
Industry Analysis
The Private Equity Takeover of Consumer Brands
Private equity firms now own thousands of consumer brands. Learn how PE reshapes the products you buy, from beauty to food to retail, and what it means.
Who Brands StaffFeb 2, 2026
private-equitybrand-ownershipacquisitions
News & Updates
Monthly M&A Roundup: April 2026 Brand Ownership Changes
Global M&A reached a record $1.3 trillion in Q1 2026, and April is continuing the momentum. McCormick is buying Unilever's food business for $45 billion. Paramount and Warner Bros. Discovery are merging. Here is every major brand ownership shift entering April 2026.
Who Brands StaffApr 12, 2026
m-and-a-roundupacquisitionsnews